Vanda Pharmaceuticals Stock One Year Return
| VNDA Stock | USD 4.78 0.15 3.24% |
Vanda Pharmaceuticals fundamentals help investors to digest information that contributes to Vanda Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Vanda Stock. The fundamental analysis module provides a way to measure Vanda Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vanda Pharmaceuticals stock.
Vanda |
Vanda Pharmaceuticals Company One Year Return Analysis
Vanda Pharmaceuticals' One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
More About One Year Return | All Equity Analysis
One Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
| Competition |
Based on the recorded statements, Vanda Pharmaceuticals has an One Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Vanda One Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vanda Pharmaceuticals' direct or indirect competition against its One Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vanda Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Vanda Pharmaceuticals by comparing valuation metrics of similar companies.Vanda Pharmaceuticals is currently under evaluation in one year return category among its peers.
Vanda Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Vanda Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Vanda Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Vanda Fundamentals
| Return On Equity | -0.0302 | ||||
| Return On Asset | -0.0364 | ||||
| Profit Margin | (0.09) % | ||||
| Operating Margin | (0.23) % | ||||
| Current Valuation | (89.9 M) | ||||
| Shares Outstanding | 58.31 M | ||||
| Shares Owned By Insiders | 3.15 % | ||||
| Shares Owned By Institutions | 76.98 % | ||||
| Number Of Shares Shorted | 3.09 M | ||||
| Price To Earning | 24.83 X | ||||
| Price To Book | 0.51 X | ||||
| Price To Sales | 1.46 X | ||||
| Revenue | 192.64 M | ||||
| Gross Profit | 230.1 M | ||||
| EBITDA | (13.95 M) | ||||
| Net Income | 2.51 M | ||||
| Cash And Equivalents | 440.86 M | ||||
| Cash Per Share | 7.79 X | ||||
| Total Debt | 9.4 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 5.62 X | ||||
| Book Value Per Share | 9.28 X | ||||
| Cash Flow From Operations | 12.8 M | ||||
| Short Ratio | 5.23 X | ||||
| Earnings Per Share | (0.19) X | ||||
| Price To Earnings To Growth | (2.42) X | ||||
| Target Price | 10.43 | ||||
| Number Of Employees | 203 | ||||
| Beta | 0.77 | ||||
| Market Capitalization | 314.86 M | ||||
| Total Asset | 648.44 M | ||||
| Retained Earnings | (155.39 M) | ||||
| Working Capital | 345.25 M | ||||
| Current Asset | 166.55 M | ||||
| Current Liabilities | 51.32 M | ||||
| Net Asset | 648.44 M |
About Vanda Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vanda Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vanda Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vanda Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vanda Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vanda Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vanda Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vanda Pharmaceuticals Stock:Check out Vanda Pharmaceuticals Piotroski F Score and Vanda Pharmaceuticals Altman Z Score analysis. For information on how to trade Vanda Stock refer to our How to Trade Vanda Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vanda Pharmaceuticals. If investors know Vanda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vanda Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (0.19) | Revenue Per Share 3.293 | Quarterly Revenue Growth 0.228 | Return On Assets (0.04) |
The market value of Vanda Pharmaceuticals is measured differently than its book value, which is the value of Vanda that is recorded on the company's balance sheet. Investors also form their own opinion of Vanda Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vanda Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vanda Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vanda Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vanda Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vanda Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vanda Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.